Literature DB >> 30740931

Three Quality Improvement Initiatives and Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results From an Interrupted Time Series Study.

Julie Gandrup1, Jing Li1, Zara Izadi1, Milena Gianfrancesco1, Torkell Ellingsen2, Jinoos Yazdany1, Gabriela Schmajuk3.   

Abstract

OBJECTIVE: Applying treat-to-target strategies in the care of patients with rheumatoid arthritis (RA) is critical for improving outcomes, yet electronic health records (EHRs) have few features to facilitate this goal. We undertook this study to evaluate the effect of 3 health information technology (health-IT) initiatives on the performance of RA disease activity measures and outcomes in an academic rheumatology clinic.
METHODS: We implemented the 3 following initiatives designed to facilitate performance of the Clinical Disease Activity Index (CDAI): an EHR flowsheet to input scores, peer performance reports, and an EHR SmartForm including a CDAI calculator. We performed an interrupted time-series trial to assess effects on the proportion of RA visits with a documented CDAI. Mean CDAI scores before and after the last initiative were compared using t-tests. Additionally, we measured physician satisfaction with the initiatives.
RESULTS: We included data from 995 patients with 8,040 encounters between 2012 and 2017. Over this period, electronic capture of CDAI scores increased from 0% to 64%. Performance remained stable after peer reporting and the SmartForm were introduced. We observed no meaningful changes in disease activity levels. However, physician satisfaction increased after SmartForm implementation.
CONCLUSION: Modifications to the EHR, provider culture, and clinical workflows effectively improved capture of RA disease activity scores and physician satisfaction, but parallel gains in disease activity levels were missing. This study illustrates how a series of health-IT initiatives can evolve to enable sustained changes in practice. However, capture of RA outcomes alone may not be sufficient to improve levels of disease activity without a comprehensive treat-to-target program.
© 2019, American College of Rheumatology.

Entities:  

Mesh:

Year:  2020        PMID: 30740931      PMCID: PMC6689446          DOI: 10.1002/acr.23848

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  25 in total

1.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

2.  Quantifying the impact of health IT implementations on clinical workflow: a new methodological perspective.

Authors:  Kai Zheng; Hilary M Haftel; Ronald B Hirschl; Michael O'Reilly; David A Hanauer
Journal:  J Am Med Inform Assoc       Date:  2010 Jul-Aug       Impact factor: 4.497

3.  Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

Authors:  C F Allaart; Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; F C Breedveld; B A C Dijkmans
Journal:  Clin Exp Rheumatol       Date:  2006 Nov-Dec       Impact factor: 4.473

Review 4.  Use of interrupted time series analysis in evaluating health care quality improvements.

Authors:  Robert B Penfold; Fang Zhang
Journal:  Acad Pediatr       Date:  2013 Nov-Dec       Impact factor: 3.107

5.  A rheumatology-specific informatics-based application with a disease activity calculator.

Authors:  Deborah S Collier; Jonathan Kay; Greg Estey; Dominic Surrao; Henry C Chueh; Richard W Grant
Journal:  Arthritis Rheum       Date:  2009-04-15

6.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Authors:  Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

Review 7.  Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.

Authors:  Michaela A Stoffer; Monika M Schoels; Josef S Smolen; Daniel Aletaha; Ferdinand C Breedveld; Gerd Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Boulos Haraoui; Juan Gomez-Reino; Tore K Kvien; Peter Nash; Victoria Navarro-Compán; Marieke Scholte-Voshaar; Ronald van Vollenhoven; Désirée van der Heijde; Tanja A Stamm
Journal:  Ann Rheum Dis       Date:  2015-05-19       Impact factor: 19.103

8.  Interrupted time series regression for the evaluation of public health interventions: a tutorial.

Authors:  James Lopez Bernal; Steven Cummins; Antonio Gasparrini
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

Review 9.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

10.  Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.

Authors:  Evo Alemao; Seongjung Joo; Hugh Kawabata; Maiwenn J Al; Paul D Allison; Maureen P M H Rutten-van Mölken; Michelle L Frits; Christine K Iannaccone; Nancy A Shadick; Michael E Weinblatt
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-03       Impact factor: 4.794

View more
  3 in total

1.  A continuous data driven translational model to evaluate effectiveness of population-level health interventions: case study, smoking ban in public places on hospital admissions for acute coronary events.

Authors:  Hossein Bonakdari; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  J Transl Med       Date:  2020-12-09       Impact factor: 5.531

2.  The Relationship Between Electronic Health Record System and Performance on Quality Measures in the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry: Observational Study.

Authors:  Nevin Hammam; Zara Izadi; Jing Li; Michael Evans; Julia Kay; Stephen Shiboski; Gabriela Schmajuk; Jinoos Yazdany
Journal:  JMIR Med Inform       Date:  2021-11-12

3.  Validation of a machine learning approach to estimate Clinical Disease Activity Index Scores for rheumatoid arthritis.

Authors:  Alison K Spencer; Jigar Bandaria; Michelle B Leavy; Benjamin Gliklich; Zhaohui Su; Gary Curhan; Costas Boussios
Journal:  RMD Open       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.